Kyle Guse
2020
In 2020, Kyle Guse earned a total compensation of $1.4M as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics, a 41% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $189,475 |
|---|---|
| Option Awards | $761,335 |
| Salary | $421,056 |
| Other | $13,600 |
| Total | $1,385,466 |
Guse received $761.3K in option awards, accounting for 55% of the total pay in 2020.
Guse also received $189.5K in non-equity incentive plan, $421.1K in salary and $13.6K in other compensation.
Rankings
In 2020, Kyle Guse's compensation ranked 7,199th out of 13,090 executives tracked by ExecPay. In other words, Guse earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,199 out of 13,090 | 45th |
Division Manufacturing | 3,009 out of 5,620 | 47th |
Major group Chemicals And Allied Products | 1,215 out of 2,253 | 46th |
Industry group Drugs | 1,048 out of 1,953 | 46th |
Industry Pharmaceutical Preparations | 782 out of 1,458 | 46th |
Source: SEC filing on April 15, 2021.
Guse's colleagues
We found one more compensation record of an executive who worked with Kyle Guse at Atossa Genetics in 2020.
2020
Steven Quay
Atossa Genetics
Chief Executive Officer
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019